Peter Jindra

Jindra

Peter Jindra, Ph.D., F(ACHI)

Associate Professor, Director of the Immune Evaluation Laboratory

(713) 798-2425

Positions

Associate Professor, Director of the Immune Evaluation Laboratory
Division of Abdominal Transplantation
Baylor College of Medicine

Addresses

Immune Evaluation Laboratory (Lab)
Methodist Neurosensory Bldg
4th Floor Room: NA-404
Houston, TX, 77030
United States
Phone: (713) 798-3005
https://www.bcm.edu/departments/surgery/divisions/abdominal-transplantation/hla-lab

Education

BS from University of California Santa Barbara
Santa Barbara
Biochemistry
PhD from University of California Los Angeles
Los Angeles, United States
Cellular and Molecular Pathology
Fellowship at Brigham and Women’s Hospital
Boston
T32
Clinical Fellowship at Albany Medical College
Albany
Clinical Fellowship at Stanford
Palo Alto, California, United States

Certifications

Board Certified
ABHI

Honors & Awards

2023 Faculty Excellence Award for Teaching and Evaluation
Norton Rose Fulbright

Professional Interests

  • High Resolution HLA typing
  • Anti-HLA antibodies
  • Clinical Trials Research
  • Chimerism
  • Function of microRNA in lymphocytes
  • Cell-free DNA

Professional Statement

Dr. Peter Jindra specializes in Transplant Diagnostic Testing and is the Laboratory Director at the BCM Immune Evaluation Laboratory. He is certified by the American Board of Histocompatibility and Immunogenetics. His research interests include the role of anti-HLA antibodies in transplant rejection, next generation sequencing of HLA molecules with epitope matching, chimerism for clinical diagnostic purposes, and providing HLA services for clinical trials.

Websites

Immune Evaluation Laboratory
The BCM Immune Evaluation Laboratory is a reference lab for solid organ transplants (kidney, heart, pancreas, liver and lung) performed in the Texas Medical Center.

Selected Publications

Memberships

American Society of Transplantation
American Society of Histocompatibility and Immunogenetics

Funding

HLA Disease Association with NeuroMyelitis Optica
Grant funding from Feinstein Institute
HLA typing patients with Neuromyelitis Optica
Safety and Efficacy of Intramyocardial Injection of Mesenchymal Precursor Cells on Myocardial Function in LVAD Recipients.
Grant funding from MesoBlast
AMICI Trial
Grant funding from Mesoblast
Study DR001
Grant funding from Mesoblast
Study DR003
Grant funding from Mesoblast
Analysis of cell-free DNA to detect rejection in pediatric heart transplant patients
Grant funding from Texas Children's Innovation Grant

Log In to edit your profile